Table 2.

Characteristics of the patients without a history of concomitant comorbid inflammatory disease

Case ID	Age at diagnosis of HS, years	Age at diagnosis of IED, years	Sex	Race	Type of IED	Laterality	Treatment	HS stage
1	41	53	Female	African-American	Iridocyclitis	Bilateral	Improved	II
2	52	59	Female	African-American	Anterior uveitis	Unilateral	Topical steroid → remission	I
3	49	56	Male	African-American	Scleritis	Unilateral	Topical steroid for 3 months → failed → 2 months of 60 mg daily prednisone → remission → topical steroid for 3 years → remission	I
4	38	41	Female	African-American	Scleritis	Unilateral	Topical steroid for 9 months → failure → 60 mg daily prednisone for 1 year → failure → adalimumab stopped due to financial problem
5	37	33	Female	Caucasian	Scleritis	Unilateral	Topical steroid → improved	II
6	49	48	Female	Caucasian	Iritis	Unilateral	Methotrexate 10–15 weekly → not known Topical steroid → improved
7	51	46	Female	Caucasian	Panuveitis	Bilateral	Topical steroid → improved

HS: hidradenitis suppurativa; IED: inflammatory eye disease